A bold ambition rewriting the narrative in kidney disease: Kidney Action Week

Coinciding with Kidney Action Week (1-7 July), Chris Forbes, CEO of Kidney Health Australia, and Professor Carol Pollock AO, nephrologist and Board Chair of Kidney Health Australia, peel back the layers of a health burden too often ignored – and reveal a national strategy that is anything but business as usual.

Professor Pollock opens the conversation with a sharp analysis of how far we have come in diagnosing and managing kidney disease. Forbes cuts through the noise, exposing the systemic barriers patients face, from late diagnosis to life-altering treatment delays. It is clear the clinical landscape has evolved but that progress has not yet translated to equity or access for all Australians.

But this is not a story of despair. It is a story of disruption. At the heart of the discussion is Kidney Health Australia’s bold campaign to End Dialysis by 2050. It is a line in the sand, and one that the duo believe is achievable with the right mix of political will, innovation, and advocacy.

Professor Pollock does not hold back when asked about the role of clinicians in medico-political advocacy. She argues that the time for passive observation is over. Doctors must speak out – not just in consultation rooms, but in Canberra.

The conversation gains global gravity with the recent World Health Assembly resolution elevating kidney disease to the world stage for the first time. The duo unpack what this moment means for the nation and how a re-elected Labor government with a commanding parliamentary majority can no longer afford to look away.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.